The Charcot foot in diabetes

Lee C. Rogers; Robert G. Frykberg; David G. Armstrong; Andrew J M Boulton; Michael Edmonds; Georges Ha Van; Agnes Hartemann; Frances Game; William Jeffcoate; Alexandra Jirkovska; Edward Jude; Stephan Morbach; William B. Morrison; Michael Pinzur; Dario Pitocco; Lee Sanders; Dane K. Wukich; Luigi Uccioli; LC Rogers; RG Frykberg; DG Armstrong; GH Van; WB Morrison; DK Wukich

doi:10.2337/dc11-0844

The Charcot foot in diabetes

Lee C. Rogers, Robert G. Frykberg, David G. Armstrong, Andrew J M Boulton, Michael Edmonds, Georges Ha Van, Agnes Hartemann, Frances Game, William Jeffcoate, Alexandra Jirkovska, Edward Jude, Stephan Morbach, William B. Morrison, Michael Pinzur, Dario Pitocco, Lee Sanders, Dane K. Wukich, Luigi Uccioli, LC Rogers, RG FrykbergDG Armstrong, GH Van, WB Morrison, DK Wukich

Research output: Contribution to journal › Article › peer-review

Abstract

The diabetic Charcot foot syndrome is a serious and potentially limb-threatening lower-extremity complication of diabetes. First described in 1883, this enigmatic condition continues to challenge even the most experienced practitioners. Now considered an inflammatory syndrome, the diabetic Charcot foot is characterized by varying degrees of bone and joint disorganization secondary to underlying neuropathy, trauma, and perturbations of bone metabolism. An international task force of experts was convened by the American Diabetes Association and the American Podiatric Medical Association in January 2011 to summarize available evidence on the pathophysiology, natural history, presentations, and treatment recommendations for this entity. © 2011 by the American Diabetes Association and the American Podiatric Medical Association.

Original language	English
Pages (from-to)	2123-2129
Number of pages	6
Journal	Diabetes Care
Volume	34
Issue number	9
DOIs	https://doi.org/10.2337/dc11-0844
Publication status	Published - Sept 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2337/dc11-0844

http://care.diabetesjournals.org/content/34/9/2123.full.pdf+html

Cite this

Rogers, L. C., Frykberg, R. G., Armstrong, D. G., Boulton, A. J. M., Edmonds, M., Ha Van, G., Hartemann, A., Game, F., Jeffcoate, W., Jirkovska, A., Jude, E., Morbach, S., Morrison, W. B., Pinzur, M., Pitocco, D., Sanders, L., Wukich, D. K., Uccioli, L., Rogers, LC., ... Wukich, DK. (2011). The Charcot foot in diabetes. Diabetes Care, 34(9), 2123-2129. https://doi.org/10.2337/dc11-0844

@article{78306617ac654b85abe277d367c8039f,

title = "The Charcot foot in diabetes",

abstract = "The diabetic Charcot foot syndrome is a serious and potentially limb-threatening lower-extremity complication of diabetes. First described in 1883, this enigmatic condition continues to challenge even the most experienced practitioners. Now considered an inflammatory syndrome, the diabetic Charcot foot is characterized by varying degrees of bone and joint disorganization secondary to underlying neuropathy, trauma, and perturbations of bone metabolism. An international task force of experts was convened by the American Diabetes Association and the American Podiatric Medical Association in January 2011 to summarize available evidence on the pathophysiology, natural history, presentations, and treatment recommendations for this entity. {\textcopyright} 2011 by the American Diabetes Association and the American Podiatric Medical Association.",

author = "Rogers, {Lee C.} and Frykberg, {Robert G.} and Armstrong, {David G.} and Boulton, {Andrew J M} and Michael Edmonds and {Ha Van}, Georges and Agnes Hartemann and Frances Game and William Jeffcoate and Alexandra Jirkovska and Edward Jude and Stephan Morbach and Morrison, {William B.} and Michael Pinzur and Dario Pitocco and Lee Sanders and Wukich, {Dane K.} and Luigi Uccioli and LC Rogers and RG Frykberg and DG Armstrong and GH Van and WB Morrison and DK Wukich",

year = "2011",

month = sep,

doi = "10.2337/dc11-0844",

language = "English",

volume = "34",

pages = "2123--2129",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association ",

number = "9",

}

Rogers, LC, Frykberg, RG, Armstrong, DG, Boulton, AJM, Edmonds, M, Ha Van, G, Hartemann, A, Game, F, Jeffcoate, W, Jirkovska, A, Jude, E, Morbach, S, Morrison, WB, Pinzur, M, Pitocco, D, Sanders, L, Wukich, DK, Uccioli, L, Rogers, LC, Frykberg, RG, Armstrong, DG, Van, GH, Morrison, WB & Wukich, DK 2011, 'The Charcot foot in diabetes', Diabetes Care, vol. 34, no. 9, pp. 2123-2129. https://doi.org/10.2337/dc11-0844

TY - JOUR

T1 - The Charcot foot in diabetes

AU - Rogers, Lee C.

AU - Frykberg, Robert G.

AU - Armstrong, David G.

AU - Boulton, Andrew J M

AU - Edmonds, Michael

AU - Ha Van, Georges

AU - Hartemann, Agnes

AU - Game, Frances

AU - Jeffcoate, William

AU - Jirkovska, Alexandra

AU - Jude, Edward

AU - Morbach, Stephan

AU - Morrison, William B.

AU - Pinzur, Michael

AU - Pitocco, Dario

AU - Sanders, Lee

AU - Wukich, Dane K.

AU - Uccioli, Luigi

AU - Rogers, LC

AU - Frykberg, RG

AU - Armstrong, DG

AU - Van, GH

AU - Morrison, WB

AU - Wukich, DK

PY - 2011/9

Y1 - 2011/9

N2 - The diabetic Charcot foot syndrome is a serious and potentially limb-threatening lower-extremity complication of diabetes. First described in 1883, this enigmatic condition continues to challenge even the most experienced practitioners. Now considered an inflammatory syndrome, the diabetic Charcot foot is characterized by varying degrees of bone and joint disorganization secondary to underlying neuropathy, trauma, and perturbations of bone metabolism. An international task force of experts was convened by the American Diabetes Association and the American Podiatric Medical Association in January 2011 to summarize available evidence on the pathophysiology, natural history, presentations, and treatment recommendations for this entity. © 2011 by the American Diabetes Association and the American Podiatric Medical Association.

AB - The diabetic Charcot foot syndrome is a serious and potentially limb-threatening lower-extremity complication of diabetes. First described in 1883, this enigmatic condition continues to challenge even the most experienced practitioners. Now considered an inflammatory syndrome, the diabetic Charcot foot is characterized by varying degrees of bone and joint disorganization secondary to underlying neuropathy, trauma, and perturbations of bone metabolism. An international task force of experts was convened by the American Diabetes Association and the American Podiatric Medical Association in January 2011 to summarize available evidence on the pathophysiology, natural history, presentations, and treatment recommendations for this entity. © 2011 by the American Diabetes Association and the American Podiatric Medical Association.

U2 - 10.2337/dc11-0844

DO - 10.2337/dc11-0844

M3 - Article

SN - 0149-5992

VL - 34

SP - 2123

EP - 2129

JO - Diabetes Care

JF - Diabetes Care

IS - 9

ER -

The Charcot foot in diabetes

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this